Aileron Therapeutics Statistics
Total Valuation
ALRN has a market cap or net worth of $59.59 million. The enterprise value is $47.52 million.
Market Cap | 59.59M |
Enterprise Value | 47.52M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, after market close.
Earnings Date | Aug 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ALRN has 21.59 million shares outstanding. The number of shares has increased by 82.81% in one year.
Shares Outstanding | 21.59M |
Shares Change (YoY) | +82.81% |
Shares Change (QoQ) | +73.99% |
Owned by Insiders (%) | 0.63% |
Owned by Institutions (%) | 23.28% |
Float | 19.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.65 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.82, with zero debt.
Current Ratio | 2.82 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.80% and return on invested capital (ROIC) is -20.22%.
Return on Equity (ROE) | -33.80% |
Return on Assets (ROA) | -31.10% |
Return on Capital (ROIC) | -20.22% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.20M |
Employee Count | 15 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.19% in the last 52 weeks. The beta is 2.10, so ALRN's price volatility has been higher than the market average.
Beta (5Y) | 2.10 |
52-Week Price Change | +46.19% |
50-Day Moving Average | 3.60 |
200-Day Moving Average | 3.48 |
Relative Strength Index (RSI) | 25.44 |
Average Volume (20 Days) | 90,574 |
Short Selling Information
The latest short interest is 140,356, so 0.65% of the outstanding shares have been sold short.
Short Interest | 140,356 |
Short Previous Month | 239,233 |
Short % of Shares Out | 0.65% |
Short % of Float | 0.71% |
Short Ratio (days to cover) | 3.05 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -18.47M |
Pretax Income | -18.07M |
Net Income | -18.07M |
EBITDA | -17.93M |
EBIT | -18.07M |
Earnings Per Share (EPS) | -$3.22 |
Balance Sheet
The company has $12.07 million in cash and no debt, giving a net cash position of $12.07 million or $0.56 per share.
Cash & Cash Equivalents | 12.07M |
Total Debt | n/a |
Net Cash | 12.07M |
Net Cash Per Share | $0.56 |
Equity (Book Value) | 91.33M |
Book Value Per Share | 4.23 |
Working Capital | 8.23M |
Cash Flow
In the last 12 months, operating cash flow was -$20.42 million and capital expenditures $42,000, giving a free cash flow of -$20.38 million.
Operating Cash Flow | -20.42M |
Capital Expenditures | 42,000 |
Free Cash Flow | -20.38M |
FCF Per Share | -$2.45 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ALRN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -82.81% |
Shareholder Yield | -82.81% |
Earnings Yield | -30.32% |
FCF Yield | -34.20% |
Analyst Forecast
The average price target for ALRN is $19.00, which is 588.41% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $19.00 |
Price Target Difference | 588.41% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -25.19% |
Stock Splits
The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.
Last Split Date | Nov 11, 2022 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |